ICD-10 Coding for Primary Myelofibrosis(C94.4, D47.4, D47.4B)
Comprehensive guide on ICD-10 coding for primary myelofibrosis, including documentation requirements and coding pitfalls.
Complete code families applicable to Primary Myelofibrosis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D47.4 | Osteomyelofibrosis | Use for confirmed cases of primary myelofibrosis with appropriate clinical documentation. |
|
| D75.81 | Myelofibrosis | Use for secondary myelofibrosis or when primary status is not specified. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPrimary Myelofibrosis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Primary Myelofibrosis.
Documenting 'myelofibrosis' without specifying primary or secondary.
Impact
Clinical: Leads to potential misclassification of the condition., Regulatory: Non-compliance with coding specificity requirements., Financial: May affect reimbursement due to incorrect DRG assignment.
Mitigation
Always specify 'primary' or 'secondary' in documentation., Query provider if documentation is unclear.
Using D75.81 for JAK2+ PMF with grade 2 fibrosis.
Impact
Reimbursement: Incorrect DRG assignment leading to reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Query provider to confirm 'primary' vs. 'secondary' etiology.
Incorrect Code Usage
Impact
Using D75.81 for primary myelofibrosis cases.
Mitigation
Implement regular training on distinguishing primary vs. secondary myelofibrosis.